Pharma & Life Sciences

Discovery on Target - Pharmaceutical

Discovery on Target is a top drug discovery conference focusing on the science, technology, and people driving the future of drug discovery. It showcases breakthroughs in therapeutic innovation across small molecules, antibodies, and emerging modalities for drug discovery leaders.

Official websiteRegisterAgenda
8 weeks until it opens.

The essentials

Event details

Dates
28 September 2026 to 1 October 2026
Location
Boston, United States
Organiser
Cambridge Innovation Institute
Expected attendance
1,100
Industry
Pharma & Life Sciences

Public discussion

What people are saying

Agenda themes

Topics covered

  • Induced Proximity-Based Drug Discovery
  • Generative AI/Machine Learning-Driven Drug Design
  • Emerging Drug Targets
  • Novel Drug Modalities
  • PROTACs/Degraders, Molecular Glues and Proximity Inducers
  • Al/ML and Screening Tools for Discovering New Drug Entities
  • Lead Generation Strategies
  • Biophysical Approaches
  • GPCR-Targeted Discovery
  • Library Innovations: DEL, FBDD, Covalent, D2B
  • Innovative Discovery Technologies
  • Al/ML-Enabled Target Identification and Lead Discovery

On stage

Speakers

  • Chris Adams, CEO, Andarix Pharmaceuticals
  • Dr. Hassan A. Ali, Associate Professor, University of Miami Miller School of Medicine
  • Angelo Andres, Associate Principal Scientist, AstraZeneca
  • Ken Lin, CEO & Founder, ABIES Capital

Logistics

Where to stay

Places to stay near the venue.

Keep planning

Related events

Spot something wrong on this page? Report a correction and we will fix it.